We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Biomarkers Identify Individuals at Risk of Heart Attack or Stroke

By LabMedica International staff writers
Posted on 20 Nov 2019
Print article
Image: Illustration depicting the effects of high blood pressure (Photo courtesy of Wikimedia Commons)
Image: Illustration depicting the effects of high blood pressure (Photo courtesy of Wikimedia Commons)
A recent study found that elevated levels of high-sensitivity cardiac troponin T or NT-proBNP characterized individuals with elevated blood pressure (BP) or hypertension not currently recommended for anti-hypertensive medication who are at high risk for cardiovascular (CV) events such as heart attack or stroke.

Cardiac troponin T (cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are biomarkers of chronic myocardial injury and stress. These proteins are detectable in the general population and are associated with adverse cardiovascular events. Whether these biomarkers can influence CV risk stratification and treatment decisions among adults with elevated BP and hypertension is unclear.

Investigators at the University of Texas Southwestern Medical Center (Dallas, TX, USA) hypothesized that elevated levels of these biomarkers could identify individuals with elevated BP or hypertension not currently recommended for pharmacological treatment who may benefit from antihypertensive medication.

To test this theory, the investigators analyzed data from 12,987 participants of three studies: Atherosclerosis Risk in Communities Study, the Dallas Heart Study, and the Multi-Ethnic Study of Atherosclerosis. The participants were of mean age 55 years, with 55% being female. Members of the group experienced 825 cardiovascular events, such as heart attacks and strokes, over a median follow-up time of 10 years.

Results of the analysis revealed that elevated high-sensitivity cardiac troponin T or NT-proBNP identified individuals with elevated BP or hypertension not currently recommended for antihypertensive medication who were at high risk for CV events. The presence of nonelevated levels of the biomarkers, even in the setting of stage I or stage II hypertension, was associated with lower risk.

"One of the proteins, high sensitivity troponin, measures injury to the heart muscle, and the other, called NT-proBNP, measures stress on the heart muscle," said senior author Dr. Joshi Pandey, assistant professor of internal medicine at the University of Texas Southwestern Medical Center. "The presence of these proteins is indicative of subtle long-term cardiac injury, like wear and tear over time. The process of developing heart disease can be difficult to pick up on based only on these risk factors. Now we have tests to detect markers of heart disease in people without any symptoms who are actually at higher risk for cardiovascular events. It is important to note that we have to make sure health care providers act appropriately when there is an abnormal result, and not necessarily recommend a series of tests without symptoms. We think this type of test can help in the shared decision-making process for patients who need more information about their risk. These blood tests are easily accessible and are less expensive than some other tests for risk assessment."

The study was published in the November 11, 2019, online edition of the journal Circulation.

Related Links:
University of Texas Southwestern Medical Center

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
New
Incubator
HettCube 120

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: Photoacoustic images of a splayed vessel structure underlying very light and dark skin tones (Photo courtesy of asquinha, Gubbi, and Bell, doi 10.1117/1.BIOS.2.1.012502)

New Imaging Technique Reduces Skin Tone Bias in Breast Cancer Detection

Breast cancer remains a significant global health issue, and early detection is key to successful treatment. Traditional imaging techniques like mammography often face challenges, particularly for women... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.